Ledger.Open graph →
SEC Form D · Amendment · filed April 23, 2021

Genomind, Inc

Offering
$21.1M
Sold
$6.4M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
KING OF PRUSSIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

John P. Chadwick · King of Prussia, PADirectorTom P. Hess · King of Prussia, PAExecTheresa P. Sexton · King of Prussia, PADirectorStephen P. Haller · King of Prussia, PAExecShawn P. O'Brien · King of Prussia, PAExec · DirectorBeth P. Dozoretz · King of Prussia, PADirectorJordan R. Collins · South Jordan, UTExecFabian Gomez Gutierrez · Miami, FLExecGarrett W. Smiley · Atlanta, GAExec · DirectorSamantha Shorter · Vancouver, British Columbia, CanadaDirectorMarc Fussteig · New York, NYDirectorShelloy P. Kiger · King of Prussia, PADirectorLouis C. Faust · LARAMIE, WYExec · DirectorMelissa Brandao · LARAMIE, WYExecJason C. Wrone · LARAMIE, WYExecDean C. Didato · LARAMIE, WYDirectorEdward C. Hamburg · LARAMIE, WYDirectorBeth P. Dozoretz · King of Prussia, PADirectorShelloy P. Kiger · King of Prussia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗